tiprankstipranks
Trending News
More News >
Guangdong Kanghua Healthcare Co., Ltd. Class H (HK:3689)
:3689
Hong Kong Market

Guangdong Kanghua Healthcare Co., Ltd. Class H (3689) Financial Statements

Compare
0 Followers

Guangdong Kanghua Healthcare Co., Ltd. Class H Financial Overview

Guangdong Kanghua Healthcare Co., Ltd. Class H's market cap is currently HK$648.72M. The company's EPS TTM is HK$0.049; its P/E ratio is 38.76; Guangdong Kanghua Healthcare Co., Ltd. Class H is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.06B¥ 2.04B¥ 1.85B¥ 1.95B¥ 1.75B
Gross Profit¥ 321.87M¥ 364.37M¥ 261.35M¥ 352.75M¥ 263.15M
Operating Income¥ 45.91M¥ 121.49M¥ 73.11M¥ 139.74M¥ -22.16M
EBITDA¥ 224.86M¥ 305.92M¥ 233.79M¥ 298.46M¥ 138.79M
Net Income¥ 15.34M¥ 121.06M¥ 27.74M¥ 66.92M¥ -50.06M
Balance Sheet
Cash & Short-Term Investments¥ 678.40M¥ 718.52M¥ 754.34M¥ 770.34M¥ 584.67M
Total Assets¥ 2.74B¥ 2.62B¥ 2.72B¥ 2.70B¥ 2.45B
Total Debt¥ 320.66M¥ 426.58M¥ 429.92M¥ 494.54M¥ 465.82M
Net Debt¥ 78.05M¥ 121.41M¥ 165.58M¥ 257.19M¥ 286.15M
Total Liabilities¥ 1.28B¥ 1.13B¥ 1.22B¥ 1.23B¥ 1.05B
Stockholders' Equity¥ 1.44B¥ 1.42B¥ 1.49B¥ 1.43B¥ 1.33B
Cash Flow
Free Cash Flow¥ 193.15M¥ 73.31M¥ 106.20M¥ 162.19M¥ 27.75M
Operating Cash Flow¥ 280.13M¥ 204.19M¥ 221.40M¥ 333.37M¥ 275.29M
Investing Cash Flow¥ -87.33M¥ -107.72M¥ -83.16M¥ -299.33M¥ -182.15M
Financing Cash Flow¥ -251.71M¥ -55.56M¥ -110.88M¥ 23.27M¥ -138.22M
Currency in CNY

Guangdong Kanghua Healthcare Co., Ltd. Class H Earnings and Revenue History

Guangdong Kanghua Healthcare Co., Ltd. Class H Debt to Assets

Guangdong Kanghua Healthcare Co., Ltd. Class H Cash Flow

Guangdong Kanghua Healthcare Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis